The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed fda warning bpc 157 peptide products New Details 157 FDA to weigh easing limits on unproven peptides Is BPC 157 Legal? Understanding Its Status and Implications Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law